Groups | A148T | OR 95% CI | Nt500c>g | OR 95% CI | Nt540c>t | OR 95% CI |
---|---|---|---|---|---|---|
newborns | 0 (0%) A/A | - | 6 (1.2%) G/G | - | 4 (0.8%) T/T | - |
(n = 500) | 14 (2.8%) G/A | - | 88 (17.6%) G/C | - | 62 (12.4%) C/T | - |
 | 486 (97.2%) G/G | - | 406 (81.2%) C/C | - | 434 (86.8%) C/C | - |
adults | 0 (0%) A/A | - | 9 (1.3%) G/G | - | 3 (0.4%) T/T | - |
(n = 710) | 21 (2.95%) G/A | - | 143 (20.1%) G/C | - | 83 (11.7%) C/T | - |
 | 689 (97.05%) G/G | - | 558 (78.6%) C/C | - | 625 (88%) C/C | - |
total controls (n = 1210) | 0 (0%) A/A | - | 15 (1.2%) G/G | - | 7 (0.6%) T/T | - |
 | 35 (2.89%) G/A | - | 229 (18.9%) G/C | - | 145 (12%) C/T | - |
 | 1175(97.1%)GG | - | 966 (79.8%) C/C | - | 1058(87.4%)C/C | - |
 | Allel A 1.5% | - | Allel G 10.7% | - | Allel T 6.6% | - |
MM* | 0 (0%) A/A | - | 8 (1.7%) G/G | 1.44 0.6–3.3 | 3 (0.6%) T/T | 1.14 0.3–4.3 |
(n = 471) | 33 (7%) G/A | 2.51 1.5–4.1 | 103 (21.9%) G/C | 1.24 0.9–1.6 | 64 (13.5%) C/T | 1.24 0.8–1.6 |
 | 438 (93%) G/G | 0.41 0.2–0.6 | 360 (76.4%) C/C | 0.84 0.6–1.1 | 404 (85.7%) C/C | 0.94 0.6–1.2 |
 | Allel A 3.5% | 2.51 1.5–4.0 | Allel G 12.6% | 1.24 0.9–1.5 | Allel T 7.4% | 1.14 0.9–1.5 |
melanoma ≤ 50 (n = 172) | 0 (0%) A/A | - | 1 (0.6%) G/G | 0.54 0.1–3.6 | 2 (1.2%) T/T | 2.04 0.4–9.8 |
 | 16 (9.3%) G/A | 3.42 1.9–6.4 | 32 (18.6%) G/C | 1.04 0.6–1.5 | 21 (12.2%) C/T | 1.04 0.6–1.7 |
 | 156 (90.7%) G/G | 0.32 0.2–0.5 | 139 (80.8%) C/C | 1.14 0.7–1.6 | 149 (86.6%) C/C | 0.94 0.6–1.5 |
 | Allel A 4.7% | 3.32 1.8–6.1 | Allel G 9.9% | 0.94 0.6–1.3 | Allel T 7.3% | 1.14 0.7–1.7 |
melanoma > 50 (n = 299) | 0 (0%) A/A | - | 7 (2.3%) G/G | 1.94 0.8–4.7 | 1 (0.3%) T/T | 0.64 0.1–4.7 |
 | 17 (5.7%) G/A | 2.03 1.1–3.7 | 71 (23.7%) G/C | 1.34 1.0–1.8 | 43 (14.4%) C/T | 1.24 0.9–1.8 |
 | 282 (94.3%) G/G | 0.53 0.3–0.9 | 221 (73.9%) C/C | 0.74 0.5–0.9 | 255 (85.3%) C/C | 0.84 0.6–1.2 |
 | Allel A 2.8% | 2.03 1.1–3.6 | Allel G 14.2% | 1.44 1.0–1.8 | Allel T 7.5% | 1.24 0.8–1.6 |